LMRI

Lumexa Imaging Holdings, Inc.

12.21 USD

Last updated Sep 4, 20:03 UTC

Yesterday HIGH

$12.16

Yesterday LOW

$11.58

52w HIGH

$19.45

52w LOW

$6.45

EPS

0.20

PE

61.05

Next Earnings

Nov 18, 2026

Overview News Government Trades Fundamentals

Lumexa Imaging Holdings, Inc. stock is up 8.05% since 30 days ago. The next earnings date is Nov 18, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 1 September’s closed higher than August. 100% of analysts rate it a buy.

Benzinga Newsdesk

Tue Jun 2, 2026

Lumexa Imaging Forms Strategic JV With Hospital For Special Surgery To Expand Access To Advanced Outpatient Imaging Services Across New York City Metro Area

Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, today announced the formation of a strategic joint venture with Hospital for Special Surgery (HSS), world leader in
Benzinga Newsdesk

Wed May 20, 2026

Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $9

Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and lowers the price target from $15 to $9.
Benzinga Insights

Wed May 13, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Newsdesk

Wed May 13, 2026

Lumexa Imaging shares are trading lower after the company narrowed its FY2026 sales guidance below estimates.
Benzinga Insights

Tue May 12, 2026

Lumexa Imaging Holdings Q1 2026 Earnings Call Transcript
Benzinga Newsdesk

Tue May 12, 2026

Lumexa Imaging Holdings Sees FY2026 Adj EPS $0.71-$0.77 vs $0.73 Est; Narrows FY2026 Sales Guidance from $1.045B-$1.097B to $1.045B-$1.090B vs $1.067B Est

Lumexa Imaging Holdings (NASDAQ:LMRI) is looking for FY2026 Adj EPS of $0.71-$0.77 vs $0.73 analyst estimate. Narrows FY2026 sales outlook from $1.045 billion-$1.097 billion to $1.045 billion-$1.090 billion vs $1.067
Benzinga Newsdesk

Tue May 12, 2026

Lumexa Imaging Holdings Q1 Adj. EPS $0.18 Beats $0.12 Estimate, Sales $252.500M Beat $251.004M Estimate

Lumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.12 by 50 percent. The company reported quarterly sales of $252.500 million which beat
Benzinga Insights

Tue May 12, 2026

Earnings Scheduled For May 12, 2026
Benzinga Newsdesk

Tue Apr 14, 2026

Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $15

Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and lowers the price target from $23 to $15.
Benzinga Newsdesk

Thu Apr 9, 2026

Lumexa Imaging Reiterates FY 2026 Guidance

On April 8, 2026, Lumexa Imaging Holdings, Inc. (the "Company") held a meeting and site visit where the Company reiterated its previously disclosed full year 2026 guidance.The information furnished pursuant to Item